Ain Shams University Maternity Hospital
Cairo, Egypt
NCT Number: NCT02141321
The aim of the work is to evaluate the efficacy of the sub lingual prostaglandin E1 synthetic analogue (misoprostol) before IUD insertion to facilitate the procedure in patients delivered before only by cesarean section.
Looking for future studies?
Notify Me18 year–45 year
Female
Interventional
Phase 2 / Phase 3
Cairo, Egypt
The study will be conducted at Ain Shams University Maternity Hospital. 124 women candidate for Cu T 380A IUD insertion will be enrolled in the study. Half of them will receive 400 micro gram of misoprostol (Sigma) sub lingually and the other half will receive the placebo two hours before IUD insertion.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: Misotac, Cytotec, Misotec, Prostaglandin E1 synthetic analogue
Time frame: During the procedure
The perception of pain and discomfort as described by the patient assessed by Visual Analogue Scale (VAS). The scale will be graded from 0 to 10, 0 representing no pain at all and 10 worst possible imaginable pain.
Time frame: During the procedure
The degree of difficulty of the IUD insertion judged by the investigator as the resistance met at the internal cervical os. The procedure either graded as (easy), (moderate difficulty) or (difficult) or (failed insertion).
Time frame: During the procedure and the following 24 hours.
Uterine perforation, excessive bleeding, fever, IUD expulsion or any other unexpected complications will be assessed during the procedure and followed for the next 24 hours.
Ain Shams University
Other
SUB LINGUAL MISOPROSTOL PRIOR TO IUD INSERTION IN WOMEN WITH ONLY PREVIOUS CESARIAN SECTION: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04441281
IUD Insertion
Geneva, Canton of Vaud, Switzerland
View Trial DetailsNCT04441333
IUD Insertion
Lausanne, Canton of Vaud, Switzerland
View Trial DetailsNCT04046302
IUD Insertion
Giza, Egypt
View Trial DetailsNCT02738203
Agnosia, IUD Insertion
Palo Alto, California, United States
View Trial Details